XCONOMY | 02.07.18

With New Test, Schadt’s Sema4 Aims to Broaden Scope of Newborn Screening

“Sema4, the company that computational geneticist Eric Schadt spun out of the Icahn School of Medicine at Mount Sinai last year, is making a new bet this morning. The New York and Connecticut startup is launching a diagnostic, Sema4 Natalis, meant to go well beyond the typical tests hospitals run on newborn babies to check for serious diseases…”